nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Circular RNA and its mechanisms in disease: From the bench to the clinic
|
Han, Bing |
|
|
187 |
C |
p. 31-44 |
artikel |
2 |
Editorial Board
|
|
|
|
187 |
C |
p. ii |
artikel |
3 |
ERK1/2 inhibitors: New weapons to inhibit the RAS-regulated RAF-MEK1/2-ERK1/2 pathway
|
Kidger, Andrew M. |
|
|
187 |
C |
p. 45-60 |
artikel |
4 |
Evolving targets for the treatment of atherosclerosis
|
Solanki, Ankita |
|
|
187 |
C |
p. 1-12 |
artikel |
5 |
Extracellular vesicles as potential biomarkers for alcohol- and drug-induced liver injury and their therapeutic applications
|
Cho, Young-Eun |
|
|
187 |
C |
p. 180-194 |
artikel |
6 |
Inflammasome biology, molecular pathology and therapeutic implications
|
Awad, Fawaz |
|
|
187 |
C |
p. 133-149 |
artikel |
7 |
Modulation of CYP1A1 metabolism: From adverse health effects to chemoprevention and therapeutic options
|
Mescher, Melina |
|
|
187 |
C |
p. 71-87 |
artikel |
8 |
Nutraceuticals and osteoarthritis pain
|
Wang, Angela |
|
|
187 |
C |
p. 167-179 |
artikel |
9 |
Safer approaches to therapeutic modulation of TGF-β signaling for respiratory disease
|
Lachapelle, Philippe |
|
|
187 |
C |
p. 98-113 |
artikel |
10 |
Serelaxin as a novel therapeutic opposing fibrosis and contraction in lung diseases
|
Lam, Maggie |
|
|
187 |
C |
p. 61-70 |
artikel |
11 |
Signalling pathways regulating galactosaminoglycan synthesis and structure in vascular smooth muscle: Implications for lipoprotein binding and atherosclerosis
|
Afroz, Rizwana |
|
|
187 |
C |
p. 88-97 |
artikel |
12 |
Targeting cancer stem cells in the clinic: Current status and perspectives
|
Annett, Stephanie |
|
|
187 |
C |
p. 13-30 |
artikel |
13 |
The relaxin receptor as a therapeutic target – perspectives from evolution and drug targeting
|
Bathgate, Ross A.D. |
|
|
187 |
C |
p. 114-132 |
artikel |
14 |
WNT receptor signalling in lung physiology and pathology
|
Skronska-Wasek, Wioletta |
|
|
187 |
C |
p. 150-166 |
artikel |